TOC: Todo lo que tienes que saber: Incluye capítulos de autoayuda
Palabras clave:
TOC, Transtorno Obsesivo-Compulsivo, ¿Qué es el TOC?, ¿Puede curarse el TOC?, ¿Qué hago si tengo TOC?Sinopsis
El trastorno obsesivo-compulsivo (TOC) es una enfermedad frecuente y
altamente incapacitante, que se presenta entre el 2 y el 3 % de la
población mundial. Una de cada treinta personas lo padece. La buena
noticia es que se trata de una afección que responde a los
tratamientos modernos.
En TOC: Todo lo que tienes que saber, Lynne M. Drummond y Laura J.
Edwards proporcionan las herramientas clave para entender este
trastorno, detectar sus síntomas y valorar las opciones de
tratamiento disponibles. Este libro guía a profesionales, pacientes,
familiares y demás personas interesadas, a través de la terapia de exposición
y prevención de la respuesta, un tratamiento psicológico altamente efectivo para
tratar el TOC.
Aquí se hallan las estrategias necesarias para desterrar las
imágenes y los pensamientos no deseados, lo que te permitirá aumentar
tu bienestar y crear una vida más plena y satisfactoria.
También encontrarás información acerca de otros trastornos
relacionados, como los trastornos de acumulación, excoriación y
ansiedad por enfermedad (entre otros), así como datos de
organizaciones y clínicas especializadas para tratar esta
afección.
Referencias
Alonso, P., Cuadras, D., Gabriëls, L., et al. (2015). "Deep brain stimulation for obsessive-compulsive disorder: a meta-analysis of treatment outcome and predictors of response". *PLoS One*, 10(7), e0133591.
Asociación Americana de Psiquiatría (2013). *Manual Diagnóstico y Estadístico de los Trastornos Mentales * (5ª ed.). Arlington, VA: American Psychiatric Publishing.
Birzele, L.T., Depner, M., Ege, M.J., et al. (2017). "Environmental and mucosal microbiota and their role in childhood asthma". *Allergy*, 72(1), 109--19.
Bloch, M. H., Landeros-Weisenberger, A., Kelmendi, B., et al. (2006). "A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder". *Molecular Psychiatry*, 11(7), 622--32.
Boschen, M.J., Drummond, L.M., Pillay, A., and Morton, K. (2010). "Predicting outcome of treatment for severe, treatment-resistant OCD in inpatient and community settings". *Journal of Behavior Therapy and Experimental Psychiatry*, 41, 90--5.
Dell'Osso, B., Benatti, B., Hollander, E., et al. (2016). "Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)". *International Journal of Psychiatry in Clinical Practice*, 20(4), 210--17.
Drummond, L.M., and Fineberg, N.A. (2007). "Obsessive--compulsive disorders". En G. Stein, (ed.), *College Seminars in Adult Psychiatry*. London: Gaskell, pp. 270--86.
Fineberg, N.A., Hollander, E., Pallanti, S., et al. (2020). "Clinical advances in obsessive compulsive disorder: a position statement by the International College of Obsessive Compulsive Spectrum Disorders". *International Clinical Psychopharmacology*, 35(4): 173--93. [https://doi.org/10.1097/yic.0000000000000314](https://doi.org/10.1097/yic.0000000000000314)
Fineberg, N.A., Van Ameringen, M., Drummond, L., et al. (2020). "How to manage obsessive-compulsive disorder (OCD) under COVID-19: a clinician's guide from the International College of Obsessive Compulsive Spectrum Disorders (ICOCS) and the Obsessive-Compulsive Research Network (OCRN) of the European College of Neuropsychopharmacology". *Comprehensive Psychiatry*, 100, 152174. [https://doi.org/10.1016/j.comppsych.2020.152174](https://doi.org/10.1016/j.comppsych.2020.152174)
Heller, A.C., Amar, A.P., Liu, C.Y., and Apuzzo, M.L. (2006). "Surgery of the mind and mood: a mosaic of issues in time and evolution". *Neurosurgery*, 59(4), 720--33; discussion 733--9.
Hollander, E., King, A., Deslaney K, et al. (2003). "Obsessive--compulsive behaviors in parents of multiplex autism families". *Psychiatry Research*, 117, 11--16. [https://doi.org/10.1016/S01651781(02)00304-9](https://doi.org/10.1016/S0165-1781(02)00304-9)
Humble, M.B., Uvnäs-Moberg, K., Engström, I., and Bejerot, S. (2013). "Plasma oxytocin changes and anti-obsessive response during serotonin reuptake inhibitor treatment: a placebo-controlled study". *BMC Psychiatry*, 13, 344 [https://doi.org/10.1186/1471-244X-13-344](https://doi.org/10.1186/1471-244X-13-344)
Jones, M.K., and Menzies, R.G. (1997a). "Danger Ideation Reduction Therapy (DIRT): preliminary findings with three obsessive-compulsive washers". *Behaviour Research and Therapy*, 35, 955--60.
Karno, M., Golding, J.M., Sorenson, S.B., and Burnam, M.A. (1988). "The epidemiology of obsessive-compulsive disorder in five US communities". *Archives of General Psychiatry*, 45, 1095--9.
McAlister-Williams, R.H., Baldwin, D.S., and Cantwell, R. (2017) "British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017". *Journal of Psychopharmacology*, 31(5), 519--52
Meier, S.M., Petersen, L., Schendel, D.E., et al. (2015). "Obsessive-compulsive disorder and autism spectrum disorders: longitudinal and offspring risk". *PLoS One* (Online). [https://doi.org/10.1371/journal.pone.0141703](https://doi.org/10.1371/journal.pone.0141703)
Mitchell-Heggs, N., Kelly, D., and Richardson, A. (1976). "Stereotactic limbic leucotomy -- a follow-up at 16 months". *British Journal of Psychiatry*, 128, 126
Rees, J.C. (2014). "Obsessive-compulsive disorder and gut microbiota dysregulation". *Medical Hypotheses*, 82(2), 163--6. [https://doi.org/10.1016/j.mehy.2013.11.026](https://doi.org/10.1016/j.mehy.2013.11.026)
Reid, J., Drummond, L.M., and Fineberg, N.A. (2021). "Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of randomised controlled trials". *Comprehensive Psychiatry*, 106, 152223 Disponible en: [www.sciencedirect.com/science/article/pii/S0010440X21000018](http://www.sciencedirect.com/science/article/pii/S0010440X21000018)
Simpson, H.B., Foa, E.B., Liebowitz, M. R., et al. (2013). "Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial". *JAMA Psychiatry*, 70(11), 1190--9.
Stern, R.S., and Drummond, L.M. "Exposure and self-imposed response prevention (ERP)", adaptado de Stern, R.S., and Drummond, L.M. (1991). *The Practice of Behavioural and Cognitive Psychotherapy*. Cambridge: Cambridge University Press
Tolin, D.F., Frost, R.O., and Stetekee, G. (2013). *Buried in Treasures: Help for Compulsive Acquiring, Saving, And Hoarding* (Treatments That Work). New York: Oxford University Press
Trevizol, A.P., Shiozawa, P., Cook, I.A., et al. (2016). "Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis". *The Journal of ECT*, 32(4), 262--6
Turna, J., Grosman Kaplan, K., Anglin, R., et al. (2020) "The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age and sex-matched controls: a pilot study". *Acta Psychiatrica Scandinavica*, 142(4), 337--47. [https://doi.org/10.1111/acps.13175](https://doi.org/10.1111/acps.13175)
Tyagi, H., Drummond, L.M., and Fineberg, N.A. (2010). "Treatment for obsessive compulsive disorder". *Current Psychiatry Reviews*, 6(1), 46--55
Tyagi, H., Zrinzo, L., Foltynie, T., et al. (2016). "Deep brain stimulation for severe obsessive-compulsive disorder". *International Congress of the Royal College of Psychiatrists*, EXCEL, London, 27--30 June
Uzunova, G., Hollander, E., and Shepherd, J. (2014). "The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and Fragile X syndrome". *Current Neuropharmacology* , 12(1), 71--98. [https://doi.org/10.2174/1570159X113116660046](https://doi.org/10.2174/1570159X113116660046)
Vaughan, R., O'Donnell, C., and Drummond, L.M. (2018). "Blood levels of treatment-resistant obsessive-compulsive disorder patients prescribed supra-normal dosages of sertraline". *European Neuropsychopharmacology*, 28(6), 767--768
World Health Organization. (1993). *The ICD 10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research*. Geneva: World Health Organization
